A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

Clinical trial NCT00203125 · COMPLETED

Trial details

NCT number: NCT00203125
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2000-10-01
Primary completion: 2003-01-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.